Detailed information for compound 580494

Basic information

Technical information
  • TDR Targets ID: 580494
  • Name: 1-[3-(diethylamino)propyl]spiro[pyrrolidine-3 ,1'-tetralin]-2,5-dione hydrochloride
  • MW: 364.909 | Formula: C20H29ClN2O2
  • H donors: 0 H acceptors: 2 LogP: 3.53 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCN(CCCN1C(=O)CC2(C1=O)CCCc1c2cccc1)CC.Cl
  • InChi: 1S/C20H28N2O2.ClH/c1-3-21(4-2)13-8-14-22-18(23)15-20(19(22)24)12-7-10-16-9-5-6-11-17(16)20;/h5-6,9,11H,3-4,7-8,10,12-15H2,1-2H3;1H
  • InChiKey: COLKCXOARNKEIW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1'-[3-(diethylamino)propyl]spiro[2,3-dihydro-1H-naphthalene-4,3'-pyrrolidine]-2',5'-dione hydrochloride
  • 1-[3-(diethylamino)propyl]spiro[pyrrolidine-3,1'-tetralin]-2,5-quinone hydrochloride
  • 1'-(3-diethylaminopropyl)spiro[2,3-dihydro-1H-naphthalene-4,3'-pyrrolidine]-2',5'-dione hydrochloride
  • 1-(3-diethylaminopropyl)spiro[pyrrolidine-3,1'-tetralin]-2,5-dione hydrochloride
  • 1-(3-diethylaminopropyl)spiro[pyrrolidine-3,1'-tetralin]-2,5-quinone hydrochloride
  • 74246-80-3
  • Spiro(naphthalene-1(2H),3'-pyrrolidine)-2',5'-dione, 3,4-dihydro-1'-(3-(diethylamino)propyl)-, hydrochloride, (+-)-
  • RAC-109I

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica acyl-CoA synthetase, putative 0.0023 0.0375 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0016 0.013 0.0206
Loa Loa (eye worm) hypothetical protein 0.008 0.2422 0.2422
Echinococcus granulosus muscleblind protein 0.029 1 1
Echinococcus multilocularis EGFP:Bcl2 fusion protein 0.008 0.2422 0.2422
Echinococcus granulosus Bcl 2 ous antagonist:killer 0.008 0.2422 0.2422
Plasmodium vivax enoyl-acyl carrier protein reductase 0.0188 0.6329 1
Brugia malayi AMP-binding enzyme family protein 0.0023 0.0375 0.0375
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0023 0.0375 0.0593
Schistosoma mansoni apoptosis regulator bax 0.008 0.2422 1
Entamoeba histolytica acyl-coA synthetase, putative 0.0023 0.0375 1
Plasmodium falciparum enoyl-acyl carrier reductase 0.0188 0.6329 1
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0023 0.0375 0.0593
Echinococcus granulosus EGFP:Bcl2 fusion protein 0.008 0.2422 0.2422
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0023 0.0375 0.0593
Brugia malayi Apoptosis regulator proteins, Bcl-2 family protein 0.008 0.2422 0.2422
Plasmodium vivax acyl-CoA synthetase, putative 0.0017 0.0164 0.026
Loa Loa (eye worm) apoptosis regulator protein 0.008 0.2422 0.2422
Schistosoma mansoni bcl-2 homologous antagonist/killer (bak) 0.008 0.2422 1
Loa Loa (eye worm) hypothetical protein 0.0017 0.0164 0.0164
Mycobacterium leprae NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) 0.0188 0.6329 1
Brugia malayi AMP-binding enzyme family protein 0.0023 0.0375 0.0375
Trypanosoma brucei oxidoreductase-like protein 0.0013 0 0.5
Plasmodium falciparum acyl-CoA synthetase 0.0017 0.0164 0.026
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.0375 0.0593
Echinococcus multilocularis Bcl 2 ous antagonist:killer 0.008 0.2422 0.2422
Loa Loa (eye worm) hypothetical protein 0.029 1 1
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0016 0.013 0.0206
Chlamydia trachomatis enoyl-acyl-carrier protein reductase 0.0188 0.6329 1
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0017 0.0164 0.026
Trypanosoma cruzi beta-ketoacyl-ACP reductase 0.0013 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0017 0.0164 0.0164
Brugia malayi AMP-binding enzyme family protein 0.0023 0.0375 0.0375
Trypanosoma brucei beta-ketoacyl-ACP reductase 0.0013 0 0.5
Mycobacterium ulcerans enoyl-(acyl carrier protein) reductase 0.0188 0.6329 1
Trypanosoma cruzi beta-ketoacyl-ACP reductase 0.0013 0 0.5
Mycobacterium leprae PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) 0.0023 0.0375 0.0593
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.0375 0.0593
Mycobacterium tuberculosis NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) 0.0188 0.6329 1
Loa Loa (eye worm) hypothetical protein 0.0023 0.0375 0.0375
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0023 0.0375 0.0593
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0016 0.013 0.0206
Chlamydia trachomatis acylglycerophosphoethanolamine acyltransferase 0.0017 0.0164 0.026
Loa Loa (eye worm) hypothetical protein 0.029 1 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0023 0.0375 1
Loa Loa (eye worm) hypothetical protein 0.0017 0.0164 0.0164
Mycobacterium ulcerans hypothetical protein 0.0023 0.0375 0.0593
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0023 0.0375 0.0593
Echinococcus multilocularis muscleblind protein 0.029 1 1
Trichomonas vaginalis hypothetical protein 0.0188 0.6329 0.5
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0023 0.0375 0.0593
Mycobacterium ulcerans acyl-CoA synthetase 0.0023 0.0375 0.0593
Mycobacterium tuberculosis Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) 0.0017 0.0164 0.026
Entamoeba histolytica acyl-CoA synthetase, putative 0.0023 0.0375 1
Schistosoma mansoni hypothetical protein 0.008 0.2422 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0023 0.0375 1
Loa Loa (eye worm) hypothetical protein 0.0023 0.0375 0.0375
Echinococcus multilocularis muscleblind protein 1 0.029 1 1
Trypanosoma cruzi oxidoreductase-like protein, putative 0.0013 0 0.5
Schistosoma mansoni hypothetical protein 0.008 0.2422 1
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0023 0.0375 0.0593
Loa Loa (eye worm) hypothetical protein 0.0023 0.0375 0.0375
Loa Loa (eye worm) hypothetical protein 0.0017 0.0164 0.0164
Wolbachia endosymbiont of Brugia malayi enoyl-ACP reductase 0.0188 0.6329 1
Schistosoma mansoni hypothetical protein 0.008 0.2422 1
Toxoplasma gondii enoyl-acyl carrier reductase ENR 0.0188 0.6329 1
Onchocerca volvulus 0.0023 0.0375 1
Leishmania major 4-coumarate:coa ligase-like protein 0.0023 0.0375 1
Loa Loa (eye worm) hypothetical protein 0.0017 0.0164 0.0164
Trypanosoma brucei pteridine reductase 1 0.0013 0 0.5
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0016 0.013 0.0206

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.